Opinion
2025 Health Care Outlook: Michael Hogue, APhA
By Michael Hogue, CEO, American Pharmacists Association
2025 Health Care Outlook: Ronald Piervincenzi, USP
By Ronald Piervincenzi, CEO, U.S. Pharmacopeia
2025 Health Care Outlook: Lee Ann Stember, NCPDP
By Lee Ann Stember, President, CEO National Council for Prescription Drug Programs
2025 Health Care Outlook: Chip Davis, HDA
By Chester ‘Chip’ Davis, President and CEO Healthcare Distribution Alliance (HDA).
2025 Health Care Outlook: B. Douglas Hoey, NCPA
By B. Douglas Hoey, CEO, National Community Pharmacists Association
2025 Health Care Outlook: Steve Anderson, NACDS
By Steve Anderson, President, CEO National Association of Chain Drug Stores
Drug chains forge ahead amid uncertainty
It’s fair to say that the chain drug industry is at a turning point.
Health Equity 3.0
In her keynote address, Rina Shah, senior vice president of pharmacy growth at Walgreens, described how health equity emerged as a central consideration in the drug chain’s strategic planning process and what that means going forward
It’s time to rethink the drug store model
Reimbursements have declined to a point at which pharmacies lose money when they fill some scripts.
